Esketamine for Depressed Adolescents at Imminent Suicide Risk
April 7, 2026
Adolescents with depression have approximately a fivefold increased...
Read More
Exercise Demonstrates Moderate Effects for Depression and Anxiety Across the Lifespan
March 19, 2026
A recent meta-meta-analysis examining the effects of structured exe...
Read More
Rethinking Mood Disorder Treatment with Immunometabolic Insights
March 17, 2026
While there are many stimulant and non-stimulant options targeting ...
Read More
Ketogenic Diet Shows Modest Short-Term Benefit in Treatment-Resistant Depression
March 5, 2026
Studies have suggested that a ketogenic diet –a high-fat, low-carbo...
Read More
Serial Intravenous Ketamine Infusions Not Superior to Usual Inpatient Care for Depression
February 9, 2026
Serial IV ketamine infusions are increasingly used off-label for tr...
Read More
NRX-101 Development Expanded to Include TMS for Depression
January 15, 2026
Treatment resistance is common in major depressive disorder, and tr...
Read More
Heart Rate, Cholesterol, and Weight Shifts Vary Widely Across Antidepressant Classes
December 18, 2025
Antidepressants remain among the most prescribed psychotropics worl...
Read More
FDA Approves Lumateperone as Adjunctive Treatment for Major Depressive Disorder
November 6, 2025
The FDA has approved lumateperone as an adjunctive therapy with an...
Read More
Lurasidone Efficacious for Depression Across Psychiatric Diagnoses
October 10, 2025
Depressive symptoms are a key driver of morbidity across multiple p...
Read More
Antidepressant Discontinuation Symptoms
July 28, 2025
Understanding the true incidence and severity of antidepressant dis...
Read More
Esketamine Monotherapy in Adults With Treatment-Resistant Depression
July 24, 2025
A new phase 4 randomized controlled trial evaluated the efficacy of...
Read More
Lithium Versus Quetiapine Augmentation For Treatment-Resistant Depression
July 8, 2025
A major randomized controlled trial compared the long-term clinical...
Read More